Back to today’s briefing

Story perspectives

UAE Pioneers In-Utero Gene Editing to Combat Genetic Disorders

1/29/2025

29 2

Summary

Story summary

In a groundbreaking move, UAE doctors are utilizing in-utero gene editing to combat genetic disorders in unborn babies, offering hope for preventing hereditary diseases. Simultaneously, M42 is revolutionizing healthcare with AI-driven precision medicine, enhancing diagnostics, while Sidra Medicine in Qatar is dedicated to advancing gene therapy for rare conditions, showcasing a united front against genetic challenges.

1 of 1

Story summary

In a groundbreaking move, UAE doctors are utilizing in-utero gene editing to combat genetic disorders in unborn babies, offering hope for preventing hereditary diseases. Simultaneously, M42 is revolutionizing healthcare with AI-driven precision medicine, enhancing diagnostics, while Sidra Medicine in Qatar is dedicated to advancing gene therapy for rare conditions, showcasing a united front against genetic challenges.